Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6675)
All Articles published online
|
Publishing Process of This Article
|
Feb 14, 2024 (publication date) through Oct 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Seddik H, Benass J, Berrag S, Sair A, Berraida R, Boutallaka H. Optimized sequential therapy vs 10- and 14-d concomitant therapy for eradicating Helicobacter pylori: A randomized clinical trial. World J Gastroenterol 2024; 30(6): 556-564 [PMID: 38463026 DOI: 10.3748/wjg.v30.i6.556] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v30/i6/556.htm |
| Number | Citing Articles |
| 1 |
Tehsin Ullah Khan, Mohamed Sharaf, Sohaib Khan, Khurshid Ahmad, Chen-Guang Liu.
Advanced nano-delivery systems in
H. pylori
eradication: targeting, efficacy, and clinical translation
. Expert Opinion on Drug Delivery 2025; : 1 doi: 10.1080/17425247.2025.2569642
|
| 2 |
Tianlian Yan, Jinghua Wang, Renke Zhu, Dan Ma, Jianguo Gao, Jiewei Wang, Ye Chen, Kefang Sun, Qing Gu, Lan Li. Vonoprazan improves the efficacy of bismuth quadruple therapy containing doxycycline and metronidazole as first-line Helicobacter pylori treatment in penicillin-allergic patients: a randomized controlled trial. Journal of Antimicrobial Chemotherapy 2025; 80(4): 927 doi: 10.1093/jac/dkae467
|
| 3 |
Jad Chidiac, Reine-Marie Kahwaji, Souheil Hallit, Yara Yazbeck, Bassem Akiki, Charbel Yazbeck. A Randomized, Prospective and Crossover Study, Comparing the Eradication Rate After 10 Days of Concomitant Therapy to Bismuth Quadruple Therapy Among a Sample of the Lebanese Population. Current Therapeutic Research 2025; 102: 100791 doi: 10.1016/j.curtheres.2025.100791
|